Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial

RT @nicomedbxl: @Emmanuel_microb Attendons les résultats de l’étude multicentrique belge COV-AID ! Inclusion sur base du phénotype hyper in…

RT @nicomedbxl: @Boghuma COV-AID trial, Belgium still recruiting. Open Label RCT ; 6 arms #Tocilizumab , #Anakinra, #Siltuximab alone or in…

RT @nicomedbxl: @ABsteward COV-AID trial by @KCETrials investigates combination of anti-IL6/anti-IL1 therapy in patients with a phenotype o…

RT @nicomedbxl: @ABsteward COV-AID trial by @KCETrials investigates combination of anti-IL6/anti-IL1 therapy in patients with a phenotype o…

Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial. https://t.co/dUid3S1JRm